Comera Life Sciences Holdings (CMRA)
US Market

Comera Life Sciences Holdings (CMRA) Stock Price & Analysis


CMRA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.80 - $15.30
Previous Close$0.89
Average Volume (3M)59.23K
Market Cap
Enterprise Value$18.68M
Total Cash (Recent Filing)$83.67K
Total Debt (Recent Filing)$100.00K
Price to Earnings (P/E)-0.6
Mar 16, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.38
Shares Outstanding22,302,693
10 Day Avg. Volume22,446
30 Day Avg. Volume59,232
Standard Deviation0.29
Financial Highlights & Ratios
Price to Book (P/B)-3.16
Price to Sales (P/S)31.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.67
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Comera Life Sciences Holdings’s price range in the past 12 months?
Comera Life Sciences Holdings lowest stock price was $0.80 and its highest was $15.30 in the past 12 months.
    What is Comera Life Sciences Holdings’s market cap?
    Currently, no data Available
    When is Comera Life Sciences Holdings’s upcoming earnings report date?
    Comera Life Sciences Holdings’s upcoming earnings report date is Mar 16, 2023 which is 14 days ago.
      How were Comera Life Sciences Holdings’s earnings last quarter?
      Comera Life Sciences Holdings released its earnings results on Nov 10, 2022. The company reported -$0.197 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.197.
        Is Comera Life Sciences Holdings overvalued?
        According to Wall Street analysts Comera Life Sciences Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Comera Life Sciences Holdings pay dividends?
          Comera Life Sciences Holdings does not currently pay dividends.
          What is Comera Life Sciences Holdings’s EPS estimate?
          Comera Life Sciences Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Comera Life Sciences Holdings have?
          Comera Life Sciences Holdings has 22,302,692 shares outstanding.
            What happened to Comera Life Sciences Holdings’s price movement after its last earnings report?
            Comera Life Sciences Holdings reported an EPS of -$0.197 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.893%.
              Which hedge fund is a major shareholder of Comera Life Sciences Holdings?
              Among the largest hedge funds holding Comera Life Sciences Holdings’s share is Saba Capital Management. It holds Comera Life Sciences Holdings’s shares valued at 4M.


                Comera Life Sciences Holdings Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Comera Life Sciences Holdings

                OTR Acquisition Corp is a blank check company.


                Top 5 ETFs holding CMRA

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold CMRA. The ETFs are listed according to market value of CMRA within the ETF


                Forecast EPS vs Actual EPS

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis